286
Views
9
CrossRef citations to date
0
Altmetric
RAPID COMMUNICATION

Introduction of Probiotic-Based Sanitation in the Emergency Ward of a Children’s Hospital During the COVID-19 Pandemic

, , , , , , , , , , , ORCID Icon & show all
Pages 1399-1410 | Published online: 30 Mar 2022

References

  • Chin AWH, Poon LLM. Stability of SARS-CoV-2 in different environmental conditions - authors’ reply. Lancet Microbe. 2020;1(4):e146. doi:10.1016/S2666-5247(20)30095-1
  • Kampf G, Todt D, Pfaender S, Steinmann E. Persistence of coronaviruses on inanimate surfaces and their inactivation with biocidal agents. J Hosp Infect. 2020;104(3):246–251. doi:10.1016/j.jhin.2020.01.022
  • Marques M, Domingo JL. Contamination of inert surfaces by SARS-CoV-2: persistence, stability and infectivity. A review. Environ Res. 2021;193:110559. doi:10.1016/j.envres.2020.110559
  • CDC CfDCaP. SARS-CoV-2 and surface (fomite) transmission for indoor community environments; 2021. Available from: https://www.cdc.gov/coronavirus/2019-ncov/more/science-and-research/surface-transmission.html#ref19. Accessed June 9, 2021.
  • ISS ISdS. Interim recommendations on cleaning and disinfection of non-healthcare settings during COVID-19 health emergency: surfaces, indoor environments and clothing. In: ISS COVID-19 Working Group on Biocides. ISS; Rapporto ISS COVID-19 n. 25/2020 (in Italian). 2020.
  • Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics; 2017. Available from: http://www.who.int/medicines/publications/global-priority-list-antibiotic-resistant-bacteria/en/. Accessed March 24, 2022.
  • Vandini A, Temmerman R, Frabetti A, et al. Hard surface biocontrol in hospitals using microbial-based cleaning products. PLoS One. 2014;9(9):e108598. doi:10.1371/journal.pone.0108598
  • D’Accolti M, Soffritti I, Bonfante F, Ricciardi W, Mazzacane S, Caselli E. Potential of an eco-sustainable probiotic-cleaning formulation in reducing infectivity of enveloped viruses. Viruses. 2021;13(11):2227. doi:10.3390/v13112227
  • Nabi G, Wang Y, Hao Y, Khan S, Wu Y, Li D. Massive use of disinfectants against COVID-19 poses potential risks to urban wildlife. Environ Res. 2020;188:109916. doi:10.1016/j.envres.2020.109916
  • Zhang H, Tang W, Chen Y, Yin W, Sills J. Disinfection threatens aquatic ecosystems. Science. 2020;368(6487):146–147. doi:10.1126/science.abb8905
  • Knight GM, Glover RE, McQuaid CF, et al. Antimicrobial resistance and COVID-19: interSections and implications. Elife. 2021;10. doi:10.7554/eLife.64139
  • Kampf G. Biocidal agents used for disinfection can enhance antibiotic resistance in gram-negative species. Antibiotics. 2018;7(4). doi:10.3390/antibiotics7040110
  • Wand ME, Bock LJ, Bonney LC, Sutton JM. Mechanisms of increased resistance to chlorhexidine and cross-resistance to colistin following exposure of Klebsiella pneumoniae clinical isolates to chlorhexidine. Antimicrob Agents Chemother. 2017;61(1). doi:10.1128/AAC.01162-16
  • Zeshan B, Karobari MI, Afzal N, et al. The usage of antibiotics by COVID-19 patients with comorbidities: the risk of increased antimicrobial resistance. Antibiotics. 2021;11(1). doi:10.3390/antibiotics11010035
  • Karobari MI, Khijmatgar S, Bhandary R, et al. A multicultural demographic study to analyze antibiotic prescription practices and the need for continuing education in dentistry. Biomed Res Int. 2021;2021:5599724. doi:10.1155/2021/5599724
  • ECDC. Surveillance of antimicrobial resistance in Europe – 2017; 2017. Available from: www.ecdc.europa.eu. Accessed March 24, 2022.
  • Getahun H, Smith I, Trivedi K, Paulin S, Balkhy HH. Tackling antimicrobial resistance in the COVID-19 pandemic. Bull World Health Organ. 2020;98:442–442A. doi:10.2471/BLT.20.268573
  • Caini S, Hajdu A, Kurcz A, Böröcz K. Hospital-acquired infections due to multidrug-resistant organisms in Hungary, 2005–2010. Euro Surveill. 2013;18:20352.
  • Cornejo-Juarez P, Vilar-Compte D, Perez-Jimenez C, Namendys-Silva SA, Sandoval-Hernandez S, Volkow-Fernandez P. The impact of hospital-acquired infections with multidrug-resistant bacteria in an oncology intensive care unit. Int J Infect Dis. 2015;31:31–34. doi:10.1016/j.ijid.2014.12.022
  • Allegranzi B, Bagheri Nejad S, Combescure C, et al. Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis. Lancet. 2011;377(9761):228–241. doi:10.1016/S0140-6736(10)61458-4
  • Messineo A, Marsella LT. Biological hazards and healthcare-associated infections in Italian healthcare facilities: some considerations on inspections and accountability. Ann Ig. 2015;27(6):799–807. doi:10.7416/ai.2015.2073
  • Lake JG, Weiner LM, Milstone AM, Saiman L, Magill SS, See I. Pathogen distribution and antimicrobial resistance among pediatric healthcare-associated infections reported to the national healthcare safety network, 2011–2014. Infect Cont Hosp Epidemiol. 2018;39(1):1–11. doi:10.1017/ice.2017.236
  • Wagh A, Sinha A. Prevention of healthcare-associated infections in paediatric intensive care unit. Childs Nerv Syst. 2018;34(10):1865–1870. doi:10.1007/s00381-018-3909-4
  • Cason C, D’Accolti M, Campisciano G, et al. Microbial contamination in hospital environment has the potential to colonize preterm newborns’ nasal cavities. Pathogens. 2021;10(5):615. doi:10.3390/pathogens10050615
  • Kramer A, Schwebke I, Kampf G. How long do nosocomial pathogens persist on inanimate surfaces? A systematic review. BMC Infect Dis. 2006;6:130. doi:10.1186/1471-2334-6-130
  • Otter JA, Yezli S, Salkeld JAG, French GL. Evidence that contaminated surfaces contribute to the transmission of hospital pathogens and an overview of strategies to address contaminated surfaces in hospital settings. Am J Infect Control. 2013;41(5):S6–S11. doi:10.1016/j.ajic.2012.12.004
  • Riggs MM, Sethi AK, Zabarsky TF, Eckstein EC, Jump RLP, Donskey CJ. Asymptomatic carriers are a potential source for transmission of epidemic and nonepidemic Clostridium difficile strains among long-term care facility residents. Clin Infect Dis. 2007;45(8):992–998. doi:10.1086/521854
  • Caselli E, D’Accolti M, Vandini A, et al. Impact of a probiotic-based cleaning intervention on the microbiota ecosystem of the hospital surfaces: focus on the resistome remodulation. PLoS One. 2016;11(2):e0148857. doi:10.1371/journal.pone.0148857
  • Caselli E, Arnoldo L, Rognoni C, et al. Impact of a probiotic-based hospital sanitation on antimicrobial resistance and HAI-associated antimicrobial consumption and costs: a multicenter study. Infect Drug Resist. 2019;12:501–510. doi:10.2147/IDR.S194670
  • Caselli E, Brusaferro S, Coccagna M, et al. Reducing healthcare-associated infections incidence by a probiotic-based sanitation system: a multicentre, prospective, intervention study. PLoS One. 2018;13(7):e0199616. doi:10.1371/journal.pone.0199616
  • D’Accolti M, Soffritti I, Mazzacane S, Caselli E. Fighting AMR in the healthcare environment: microbiome-based sanitation approaches and monitoring tools. Int J Mol Sci. 2019;20(7):1535. doi:10.3390/ijms20071535
  • Comar M, D’Accolti M, Cason C, et al. Introduction of NGS in environmental surveillance for healthcare-associated infection control. Microorganisms. 2019;7(12):708. doi:10.3390/microorganisms7120708
  • Quast C, Pruesse E, Yilmaz P, et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 2013;41(D1):D590–596. doi:10.1093/nar/gks1219
  • Caselli E, D’Accolti M, Soffritti I, et al. An innovative strategy for the effective reduction of MDR pathogens from the nosocomial environment. Adv Exp Med Biol. 2019;1214:79–91.
  • D’Accolti M, Soffritti I, Passaro A, et al. SARS-CoV-2 RNA contamination on surfaces of a COVID-19 ward in a hospital of Northern Italy: what risk of transmission? Eur Rev Med Pharmacol Sci. 2020;24(17):9202–9207. doi:10.26355/eurrev_202009_22872